To The Moon

$Dow Chemical(DOW)$ $CF Industries Holdings Inc(CF)$  $LyondellBasell Industries NV(LYB)$  📈⚗️ $DOW 58% YTD Surge Collides with 24-Month Resistance: Overbought Momentum Meets Bullish Options Extremes ⚗️📈

⚗️ Cyclical chemicals giant $DOW is approaching a decisive technical and probabilistic inflection point.

I am watching a textbook momentum extension now pressing directly into long-term structural resistance.

📊 Current positioning

• YTD performance approximately +58%

• Trading near 52-week highs around $37.80

• Testing the long-term 24-month moving average

The rally itself has been exceptionally steep for a cyclical chemicals company, climbing from roughly $23 in 2025 to the high $30s in less than twelve months. Moves of that magnitude in industrial cyclicals often stall when they meet long-term mean reversion levels.

📉 The technical structure reinforces that risk.

Key chart signals:

• Price pressing into a heavy multi-year supply zone between $37 and $40

• 24-month moving average acting as regime resistance

• 14-day RSI between 70 and 74, firmly in overbought territory

• Monthly structure returning to a major distribution range formed during 2023

Historical precedent for similar momentum extensions into long-term moving averages shows mixed forward outcomes.

Comparable setups have generated:

• Only about 25% probability of positive returns 30 days forward

• Average drawdown of roughly -11% over the following three months

This creates a classic trader dilemma. Lock in gains after a powerful rally, or challenge the market to extend beyond historical norms.

Options positioning adds another layer of complexity.

Put-call ratios have compressed to extreme lows, signalling aggressively bullish sentiment. While this confirms strong conviction, it also introduces a potential contrarian headwind if positioning begins to unwind.

🧠 The fundamental backdrop remains cyclical but gradually improving.

Dow Inc. continues to benefit from ethylene derivative demand strength and relatively favourable energy input costs across its chemicals portfolio.

However the earnings recovery is still developing rather than fully established.

Key fundamentals:

• Trailing twelve-month EPS remains negative

• Analysts expect profitability to return by mid-2026

• 2026 revenue growth forecast sits at a modest +0.4%

Recent analyst commentary has nudged targets higher.

• Wells Fargo target: $45

• Citigroup target: $40

Despite these upgrades, the broader consensus rating remains Hold with an average price target near $34–$35, suggesting the market already reflects much of the expected recovery.

The next major catalyst arrives with earnings on 23Apr26.

Taken together, the market is now confronting a high-stakes equilibrium between momentum, positioning and valuation. A decisive break above the $37–$40 supply zone would signal a potential new cyclical expansion phase, while failure at this level could trigger the type of mean reversion that historically follows extended chemical-sector rallies.

👉❓ If $DOW successfully breaks and holds above the 24-month moving average near $38, does that mark the beginning of a new upcycle for the global chemicals sector, or is this rally approaching exhaustion after a 58% surge?

📢 Don’t miss out! Like, Repost and Follow me for exclusive setups, cutting-edge trends, and insights that move markets 🚀📈 I’m obsessed with hunting down the next big movers and sharing strategies that crush it. Let’s outsmart the market and stack those gains together! 🍀

Trade like a boss! Happy trading ahead, Cheers, BC 📈🚀🍀🍀🍀